Hansjoerg Eibl

821 total citations
13 papers, 681 citations indexed

About

Hansjoerg Eibl is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Hansjoerg Eibl has authored 13 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Biomaterials and 2 papers in Organic Chemistry. Recurrent topics in Hansjoerg Eibl's work include Lipid Membrane Structure and Behavior (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and RNA Interference and Gene Delivery (3 papers). Hansjoerg Eibl is often cited by papers focused on Lipid Membrane Structure and Behavior (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and RNA Interference and Gene Delivery (3 papers). Hansjoerg Eibl collaborates with scholars based in Germany and United States. Hansjoerg Eibl's co-authors include Karl Harlos, Lars H. Lindner, Rolf D. Issels, Marc Dellian, M. Schmitt‐Sody, Martin Eichhorn, Horst Vogel, Wolfgang Hiddemann, Clemens Unger and Martin Hossann and has published in prestigious journals such as Biochemistry, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Hansjoerg Eibl

13 papers receiving 635 citations

Peers

Hansjoerg Eibl
A. Gulik France
S. Ohki United States
David S. Johnston United Kingdom
H. G. Weder Switzerland
Kimberly M. Taylor United States
A. Gulik France
Hansjoerg Eibl
Citations per year, relative to Hansjoerg Eibl Hansjoerg Eibl (= 1×) peers A. Gulik

Countries citing papers authored by Hansjoerg Eibl

Since Specialization
Citations

This map shows the geographic impact of Hansjoerg Eibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hansjoerg Eibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hansjoerg Eibl more than expected).

Fields of papers citing papers by Hansjoerg Eibl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hansjoerg Eibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hansjoerg Eibl. The network helps show where Hansjoerg Eibl may publish in the future.

Co-authorship network of co-authors of Hansjoerg Eibl

This figure shows the co-authorship network connecting the top 25 collaborators of Hansjoerg Eibl. A scholar is included among the top collaborators of Hansjoerg Eibl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hansjoerg Eibl. Hansjoerg Eibl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pallasch, Christian P., Lars H. Lindner, Janine Schwamb, et al.. (2010). Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway. Leukemia Research. 34(8). 1064–1069. 22 indexed citations
2.
Wang, Tungte, Martin Hossann, Herbert M. Reinl, et al.. (2008). In vitro characterization of phosphatidylglyceroglycerol‐based thermosensitive liposomes with encapsulated 1H MR T1‐shortening gadodiamide. Contrast Media & Molecular Imaging. 3(1). 19–26. 23 indexed citations
3.
Lindner, Lars H., Martin Hossann, Michael Vogeser, et al.. (2007). Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: Active ingredient and mediator of drug release. Journal of Controlled Release. 125(2). 112–120. 60 indexed citations
4.
Fiegl, Michael, et al.. (2007). Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs. Cancer Chemotherapy and Pharmacology. 62(2). 321–329. 31 indexed citations
5.
Lindner, Lars H., Roland Brock, Donna J. Arndt‐Jovin, & Hansjoerg Eibl. (2005). Structural variation of cationic lipids: Minimum requirement for improved oligonucleotide delivery into cells. Journal of Controlled Release. 110(2). 444–456. 17 indexed citations
6.
Lindner, Lars H., Martin Eichhorn, Hansjoerg Eibl, et al.. (2004). Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time. Clinical Cancer Research. 10(6). 2168–2178. 206 indexed citations
7.
Ries, Uwe J., et al.. (1993). In vitro and in vivo antitumoral activity of alkylphosphonates. European Journal of Cancer. 29(1). 96–101. 10 indexed citations
8.
Fleer, E. A. M., Dinko Berkovic, Hansjoerg Eibl, & Clemens Unger. (1993). Investigations on the cellular uptake of hexadecylphosphocholine. Lipids. 28(8). 731–736. 24 indexed citations
9.
Unger, Clemens, et al.. (1987). A continuous assay forO‐alkylglycerol monooxygenase (E.C. 1.14.16.5). Lipids. 22(11). 824–830. 13 indexed citations
10.
Tuemmler, Burkhard, et al.. (1984). Kinetics of the subtransition of asymmetrically substituted phosphatidylcholines. Biochemistry. 23(18). 4068–4074. 6 indexed citations
11.
Harlos, Karl & Hansjoerg Eibl. (1981). Hexagonal phases in phospholipids with saturated chains: phosphatidylethanolamines and phosphatidic acids. Biochemistry. 20(10). 2888–2892. 105 indexed citations
12.
Harlos, Karl & Hansjoerg Eibl. (1980). Influence of calcium on phosphatidylglycerol. Two separate lamellar structures. Biochemistry. 19(5). 895–899. 57 indexed citations
13.
Harlos, Karl, et al.. (1979). Electrostatic interactions at charged lipid membranes. Electrostatically induced tilt. Biochemistry. 18(8). 1459–1468. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026